Dermatology
Latest News
Novel single-use patch shows promise for primary axillary hyperhidrosis
“This is a new kind of device that is going to be a nice tool to have.”
Latest News
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatology
The recently approved deucravacitinib is the only JAK inhibitor that has so far been exempt from these warnings.
Conference Coverage
Lanolin gets nod for Allergen of the Year
Controversy continues over lanolin allergenicity; some patients with positive patch tests can tolerate lanolin ingredients.
Latest News
Study finds quality of topical steroid withdrawal videos on YouTube subpar
“We were disheartened that patient testimonial videos had the poorest quality and reliability of the information sources,” Erika McCormick said....
Latest News
Spironolactone: an ‘inexpensive, effective’ option for acne in women
“Spironolactone is fairly accessible, inexpensive, and effective for our patients,” Dr. Julie C. Harper said.
Latest News
Lebrikizumab monotherapy for AD found safe, effective during induction
Latest News
Spinosad: New kid on the block for treating scabies
The formulation “drives the active compound to the stratum corneum, where mites live and breed,” Dr. Anthony J. Mancini said.
Conference Coverage
Nearly one in three patients with IBD affected by skin lesions
“Skin lesions in IBD patients are much more prevalent than it is generally accepted. The lesions may be related to the pathogenesis of IBD, but it...
Opinion
White male presents with pruritic, scaly, erythematous patches on his feet and left hand
A 47-year-old patient presents with pruritic, scaly, erythematous patches on his feet and left hand.
From the Journals
Biologics show signs of delaying arthritis in psoriasis patients
Treatment with the interleukin-12/23 inhibitor ustekinumab or interleukin-23 inhibitors (guselkumab, risankizumab, tildrakizumab) was linked to a...
Latest News
FDA to review dupilumab for treating chronic spontaneous urticaria
Dupilumab enters the approval process for adolescents and adults with uncontrolled CSU.